Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Down – Here’s What Happened

Nihon Kohden Corporation (OTCMKTS:NHNKY)’s share price gapped down before the market opened on Friday. The stock had previously closed at $10.37, but opened at $9.8135. Nihon Kohden shares last traded at $9.8135, with a volume of 204 shares trading hands.

Analyst Upgrades and Downgrades

Separately, UBS Group cut Nihon Kohden from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 12th. Two equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Nihon Kohden Stock Down 5.2%

The firm has a market capitalization of $1.65 billion, a PE ratio of 17.87 and a beta of 0.38. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.64 and a current ratio of 3.98. The company’s 50 day simple moving average is $9.90 and its 200-day simple moving average is $9.48.

Nihon Kohden (OTCMKTS:NHNKY) last posted its earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.09). Nihon Kohden had a return on equity of 9.17% and a net margin of 5.90%. The firm had revenue of $297.47 million for the quarter, compared to analysts’ expectations of $299.98 million. On average, analysts forecast that Nihon Kohden Corporation will post 0.60 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and markets electronic medical equipment and related solutions. Founded in 1951 and headquartered in Tokyo, the company serves hospitals, clinics and other healthcare providers through operations in Japan and international markets.

Its product portfolio includes patient monitoring systems, electrocardiographs, electroencephalographs and other neurological diagnostic equipment. Nihon Kohden also supplies defibrillators, automated external defibrillators, ventilators, anesthesia-related equipment, clinical information systems and devices used in in-vitro diagnostics, including hematology testing.

The company distributes its products through domestic and overseas subsidiaries, distributors and service networks.